Xtant Medical Receives FDA 510(K) Clearance for InTice(TM)-C Porous Titanium Cervical Interbody System

Stock Information for Xtant Medical Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Xtant Medical Holdings Inc.

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.